Group Psychoeducation to Promote Independent Living in Individuals With Psychiatric Disorders (AUTON'HOME)

December 19, 2025 updated by: Raluca ROSETTI, Centre hospitalier de Ville-Evrard, France

Study on the Effectiveness of Group Psychoeducation (for Users and Caregivers) in Promoting Autonomy at Home for Individuals With Psychatric Disorder.

This study evaluates the effectiveness of group psychoeducation for users and carers to help people with severe psychiatric disorders achieve autonomy at home.

Study Overview

Status

Recruiting

Conditions

Detailed Description

The study will assess the autonomy of users with severe psychiatric disorders in a home setting before and after participation in the psychoeducation group. The program includes 10 sessions focusing on various aspects of daily living and cognitive functions.

Study Type

Observational

Enrollment (Estimated)

24

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Youcef BENCHERIF, Clinical Project Manager
  • Phone Number: 01.43.09.32.32
  • Email: y.bencherif@epsve.fr

Study Locations

  • France
      • Neuilly-sur-Marne, France
        • Recruiting
        • EPS VIlle Evrard - UNIRRE 93
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Participants with severe psychiatric disorders, managed by the RPS 93 platform, and volunteers for a home autonomy project.

Description

Inclusion Criteria:

  • Volunteer for a home autonomy project
  • Management of a mental health problem (mood disorder or psychotic disorder)
  • Consent for participation (non-opposition)
  • Taken care by the RPS 93 platform

Exclusion Criteria:

  • Acute clinical state

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
AUTON'HOME Group 1
Group of 6 patients with severe mental disorders (mood or psychotic disorders), residing in Seine-Saint-Denis, supported by the RPS platform. They participate in a 10-week psychoeducation program called 'AUTON'HOME', aimed at improving their autonomy at home. The program includes 10 thematic sessions on cognitive functions, daily living skills, hygiene, housing management and social participation. Evaluations are conducted before and 3 months after the program.
AUTON'HOME Group 2
Group of 6 patients with severe mental disorders (mood or psychotic disorders), residing in Seine-Saint-Denis, supported by the RPS platform. They participate in a 10-week psychoeducation program called 'AUTON'HOME', aimed at improving their autonomy at home. The program includes 10 thematic sessions on cognitive functions, daily living skills, hygiene, housing management and social participation. Evaluations are conducted before and 3 months after the program.
AUTON'HOME Group 3
Group of 6 patients with severe mental disorders (mood or psychotic disorders), residing in Seine-Saint-Denis, supported by the RPS platform. They participate in a 10-week psychoeducation program called 'AUTON'HOME', aimed at improving their autonomy at home. The program includes 10 thematic sessions on cognitive functions, daily living skills, hygiene, housing management and social participation. Evaluations are conducted before and 3 months after the program.
AUTON'HOME Group 4
Group of 6 patients with severe mental disorders (mood or psychotic disorders), residing in Seine-Saint-Denis, supported by the RPS platform. They participate in a 10-week psychoeducation program called 'AUTON'HOME', aimed at improving their autonomy at home. The program includes 10 thematic sessions on cognitive functions, daily living skills, hygiene, housing management and social participation. Evaluations are conducted before and 3 months after the program.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Life Habits Assessment Tool
Time Frame: Baseline, at the end of the 10-week AUTON'HOME psychoeducation program, and 3 months after program completion
Assessing the autonomy of users with severe psychic pathologies in housing before and after participation in the psychoeducation group.
Baseline, at the end of the 10-week AUTON'HOME psychoeducation program, and 3 months after program completion

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Center for Epidemiologic Studies Depression Scale
Time Frame: Baseline, at the end of the 10-week AUTON'HOME psychoeducation program, and 3 months after program completion
Assesses emotional impressions and depressive symptoms in caregivers.
Baseline, at the end of the 10-week AUTON'HOME psychoeducation program, and 3 months after program completion
Zarit Burden Interview Scale
Time Frame: Baseline, at the end of the 10-week AUTON'HOME psychoeducation program, and 3 months after program completion
Quantifies caregiver burden.
Baseline, at the end of the 10-week AUTON'HOME psychoeducation program, and 3 months after program completion
Family Expectations Questionnaire
Time Frame: Baseline (prior to initiation of the AUTON'HOME psychoeducation program)
It aims to collect the expectations of family members regarding the autonomy and daily functioning of their loved one living with a severe mental disorder.
Baseline (prior to initiation of the AUTON'HOME psychoeducation program)
Family Expectations Fulfillment Questionnaire
Time Frame: At the end of the 10-week AUTON'HOME psychoeducation program and 3 months after program completion
It evaluates whether the expectations previously expressed by the family have been fulfilled, partially met, or unmet.
At the end of the 10-week AUTON'HOME psychoeducation program and 3 months after program completion
Positive and Negative Syndrome Scale
Time Frame: Baseline and 3 months after completion of the 10-week AUTON'HOME psychoeducation program
Measures severity of psychiatric symptoms.
Baseline and 3 months after completion of the 10-week AUTON'HOME psychoeducation program
Clinical Global Impression
Time Frame: Baseline and 3 months after completion of the 10-week AUTON'HOME psychoeducation program
Assesses global improvement compared to baseline.
Baseline and 3 months after completion of the 10-week AUTON'HOME psychoeducation program
Montreal Cognitive Assessment
Time Frame: Baseline and 3 months after completion of the 10-week AUTON'HOME psychoeducation program
Screens for mild to moderate cognitive impairments.
Baseline and 3 months after completion of the 10-week AUTON'HOME psychoeducation program

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Centre hospitalier de Ville-Evrard, France

Investigators

  • Principal Investigator: Raluca ROSETTI, Docrorat d'Etat en Médecine, EPS Ville Evrard

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2025

Primary Completion (Estimated)

February 1, 2027

Study Completion (Estimated)

February 1, 2027

Study Registration Dates

First Submitted

September 26, 2025

First Submitted That Met QC Criteria

December 19, 2025

First Posted (Actual)

January 5, 2026

Study Record Updates

Last Update Posted (Actual)

January 5, 2026

Last Update Submitted That Met QC Criteria

December 19, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 0098_EPSVE_AUTON'HOME

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Psychiatric Disorder

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe